Cellular uptake of modified mRNA occurs via caveolae-mediated endocytosis, yielding high protein expression in slow-dividing cells
Nucleic acids have clear clinical potential for gene therapy. Plasmid DNA (pDNA) was the first nucleic acid to be pursued as a therapeutic molecule. Recently, mRNA came into play as it offers improved safety and affordability. In this study, we investigated the uptake mechanisms and efficiencies of...
Saved in:
Main Authors: | Claudia Del Toro Runzer (Author), Shivesh Anand (Author), Carlos Mota (Author), Lorenzo Moroni (Author), Christian Plank (Author), Martijn van Griensven (Author), Elizabeth R. Balmayor (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2023-06-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Unveiling the intricacies of gene delivery: Caveolae-mediated endocytosis induces efficient mRNA delivery in slow-dividing cells
by: Sabine den Roover, et al.
Published: (2023) -
Caveolae-dependent endocytosis mediates the cellular uptake of CdTe quantum dots in ovarian cancer cell lines
by: Zahra Asadian, et al.
Published: (2022) -
Allosteric inhibitor of SHP2 enhances macrophage endocytosis and bacteria elimination by increasing caveolae activation and protects against bacterial sepsis
by: Tianliang Li, et al.
Published: (2024) -
Albumin-EDTA-Vanadium Is a Powerful Anti-Proliferative Agent, Following Entrance into Glioma Cells via Caveolae-Mediated Endocytosis
by: Itzik Cooper, et al.
Published: (2021) -
Mechanism of action of Caveolae and its impact pathways
by: Xiu Du, et al.
Published: (2024)